Exosome mediated growth effect on the non-growing pre-B acute lymphoblastic leukemia cells at low starting cell density

American Journal of Translational Research

Volumn 8, Issue 9, 2016, Pages 3614-3629

  Patel, Sapan J ^a,b   Darie, Costel C ^b   Clarkson, Bayard D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b CLARKSON UNIVERSITY   (United States)

Author keywords

Acute lymphoblastic leukemia; Collective behavior; Exosome; Proliferation; Quorum sensing; Tyrosine kinase inhibitor

Indexed keywords

3 BENZYL 7 CYANO 2,3,4,5 TETRAHYDRO 1 (1H IMIDAZOL 4 YLMETHYL) 4 (2 THIENYLSULFONYL) 1H 1,4 BENZODIAZEPINE; 6 (2,6 DICHLOROPHENYL) 2 [3 (HYDROXYMETHYL)ANILINO] 8 METHYLPYRIDO[2,3 D]PYRIMIDIN 7(8H) ONE; DASATINIB; IMATINIB; NILOTINIB;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATOMIC FORCE MICROSCOPY; B ACUTE LYMPHOBLASTIC LEUKEMIA CELL; CELL DENSITY; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CELL TRANSPLANTATION; DRUG INHIBITION; EXOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; KARYOTYPING; LEUKEMIA CELL; MOUSE; NONHUMAN; PARTICLE SIZE; PHILADELPHIA 1 CHROMOSOME; PHOTON CORRELATION SPECTROSCOPY; THYMIDINE INCORPORATION ASSAY; WESTERN BLOTTING;

EID: 84988884712     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Friedl P and Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10: 445-457.
2. Greaves M. Evolutionary determinants of cancer. Cancer Discov 2015; 5: 806-820.
3. Greaves M and Maley CC. Clonal evolution in cancer. Nature 2012; 481: 306-313.
4. Kawano S, Otsu K, Kuruma A, Shoji S, Yanagida E, Muto Y, Yoshikawa F, Hirayama Y, Mikoshiba K and Furuichi T. ATP autocrine/paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium 2006; 39: 313-324.
5. Montaudouin C, Anson M, Hao Y, Duncker SV, Fernandez T, Gaudin E, Ehrenstein M, Kerr WG, Colle JH, Bruhns P, Daeron M and Freitas AA. Quorum sensing contributes to activated IgM-secreting B cell homeostasis. J Immunol 2013; 190: 106-114.
6. Patel SJ, Dao S, Darie CC and Clarkson BD. Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems. Am J Cancer Res 2016; 6: 1177-1230.
7. Perie L, Aru J, Kourilsky P and Slotine JJ. Does a quorum sensing mechanism direct the behavior of immune cells? C R Biol 2013; 336: 13-16.
8. Shim J. Drosophila blood as a model system for stress sensing mechanisms. BMB Rep 2015; 48: 223-228.
9. Chen CC, Wang L, Plikus MV, Jiang TX, Murray PJ, Ramos R, Guerrero-Juarez CF, Hughes MW, Lee OK, Shi S, Widelitz RB, Lander AD and Chuong CM. Organ-level quorum sensing directs regeneration in hair stem cell populations. Cell 2015; 161: 277-290.
10. Szabo B, Szollosi GJ, Gonci B, Juranyi Z, Selmeczi D and Vicsek T. Phase transition in the collective migration of tissue cells: experiment and model. Phys Rev E Stat Nonlin Soft Matter Phys 2006; 74: 061908.
11. Agrawal GK, Jwa NS, Lebrun MH, Job D and Rakwal R. Plant secretome: unlocking secrets of the secreted proteins. Proteomics 2010; 10: 799-827.
12. Patel S, Ngounou Wetie AG, Darie CC and Clarkson BD. Cancer secretomes and their place in supplementing other hallmarks of cancer. Adv Exp Med Biol 2014; 806: 409-442.
13. Ngounou Wetie AG, Sokolowska I, Woods AG, Wormwood KL, Dao S, Patel S, Clarkson BD and Darie CC. Automated mass spectrometry-based functional assay for the routine analysis of the secretome. J Lab Autom 2013; 18: 19-29.
14. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
15. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
16. Friedl P, Locker J, Sahai E and Segall JE. Classifying collective cancer cell invasion. Nat Cell Biol 2012; 14: 777-783.
17. Jimenez Valencia AM, Wu PH, Yogurtcu ON, Rao P, DiGiacomo J, Godet I, He L, Lee MH, Gilkes D, Sun SX and Wirtz D. Collective cancer cell invasion induced by coordinated contractile stresses. Oncotarget 2015; 6: 43438-43451.
18. Shtam TA, Kovalev RA, Varfolomeeva EY, Makarov EM, Kil YV and Filatov MV. Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Commun Signal 2013; 11: 88.
19. Taylor DD and Doellgast GJ. Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography. Anal Biochem 1979; 98: 53-59.
20. Trams EG, Lauter CJ, Salem N Jr and Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 1981; 645: 63-70.
21. Mathivanan S, Ji H and Simpson RJ. Exosomes: extracellular organelles important in intercellular communication. J Proteomics 2010; 73: 1907-1920.
22. Vlassov AV, Magdaleno S, Setterquist R and Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta 2012; 1820: 940-948.
23. Azmi AS, Bao B and Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013; 32: 623-642.
24. Willms E, Johansson HJ, Mager I, Lee Y, Blomberg KE, Sadik M, Alaarg A, Smith CI, Lehtio J, El Andaloussi S, Wood MJ and Vader P. Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep 2016; 6: 22519.
25. Song J, Huang J, Chen X, Teng X, Song Z, Xing Y, Wang M, Chen K, Wang Z, Yang P and Hu S. Donor-derived exosomes induce specific regulatory T cells to suppress immune inflammation in the allograft heart. Sci Rep 2016; 7: 20077.
26. Thery C, Ostrowski M and Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9: 581-593.
27. Budnik V, Ruiz-Canada C and Wendler F. Extracellular vesicles round off communication in the nervous system. Nat Rev Neurosci 2016; 17: 160-172.
28. Costa-Silva B, Aiello NM, Ocean AJ, Singh S, Zhang H, Thakur BK, Becker A, Hoshino A, Mark MT, Molina H, Xiang J, Zhang T, Theilen TM, Garcia-Santos G, Williams C, Ararso Y, Huang Y, Rodrigues G, Shen TL, Labori KJ, Lothe IM, Kure EH, Hernandez J, Doussot A, Ebbesen SH, Grandgenett PM, Hollingsworth MA, Jain M, Mallya K, Batra SK, Jarnagin WR, Schwartz RE, Matei I, Peinado H, Stanger BZ, Bromberg J and Lyden D. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol 2015; 17: 816-826.
29. Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, Labori KJ, Kure EH, Grandgenett PM, Hollingsworth MA, de Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J and Lyden D. Tumour exosome integrins determine organotropic metastasis. Nature 2015; 527: 329-335.
30. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, Garcia-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J and Lyden D. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18: 883-891.
31. Sung BH, Ketova T, Hoshino D, Zijlstra A and Weaver AM. Directional cell movement through tissues is controlled by exosome secretion. Nat Commun 2015; 6: 7164.
32. Clarkson B and Strife A. Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. Leukemia 1993; 7: 1683-1721.
33. Clarkson BD, Strife A, Wisniewski D, Lambek C and Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia 1997; 11: 1404-1428.
34. Clarkson B, Strife A, Wisniewski D, Lambek CL and Liu C. Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia 2003; 17: 1211-1262.
35. Greaves M. Leukaemia ‘firsts’ in cancer research and treatment. Nat Rev Cancer 2016; 16: 163-172.
36. Shen C, Hao SG, Zhao CX, Zhu J and Wang C. Antileukaemia immunity: effect of exosomes against NB4 acute promyelocytic leukaemia cells. J Int Med Res 2011; 39: 740-747.
37. Clarkson B, Katz A, Dann MA and Karnofsky DA. Behavior of P388 Mouse Leukemia in the Chick Embryo and Hatched Chick. J Natl Cancer Inst 1964; 32: 471-495.
38. Clarkson BD and Katz A. The behavior of P388 mouse leukemia in the chick embryo and hatched chick. Proc Amer Ass Cancer Res 1960.
39. Clarkson BD, Ota K and O’connor A. Stimulation of leukopoiesis in the chick embryo by heterologous tumor cells. Proc Amer Ass Cancer Res 1963; 4.
40. Szczepanski MJ, Szajnik M, Welsh A, Whiteside TL and Boyiadzis M. Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1. Haematologica 2011; 96: 1302-1309.
41. Whiteside TL. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans 2013; 41: 245-251.
42. Corrado C, Flugy AM, Taverna S, Raimondo S, Guggino G, Karmali R, De Leo G and Alessandro R. Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis. PLoS One 2012; 7: e42310.
43. Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro R and Kohn EC. Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a Src-dependent fashion. Angiogenesis 2012; 15: 33-45.
44. Taverna S, Flugy A, Saieva L, Kohn EC, Santoro A, Meraviglia S, De Leo G and Alessandro R. Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis. Int J Cancer 2012; 130: 2033-2043.
45. Feng DQ, Huang B, Li J, Liu J, Chen XM, Xu YM, Chen X, Zhang HB, Hu LH and Wang XZ. Selective miRNA expression profile in chronic myeloid leukemia K562 cell-derived exosomes. Asian Pac J Cancer Prev 2013; 14: 7501-7508.
46. Huan J, Hornick NI, Shurtleff MJ, Skinner AM, Goloviznina NA, Roberts CT Jr and Kurre P. RNA trafficking by acute myelogenous leukemia exosomes. Cancer Res 2013; 73: 918-929.
47. Wisniewski D, Lambek CL, Liu C, Strife A, Veach DR, Nagar B, Young MA, Schindler T, Bornmann WG, Bertino JR, Kuriyan J and Clarkson B. Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. Cancer Res 2002; 62: 4244-4255.
48. Sokolowska I, Woods AG, Gawinowicz MA, Roy U and Darie CC. Identification of a potential tumor differentiation factor receptor candidate in prostate cancer cells. FEBS J 2012; 279: 2579-2594.
49. Nealson KH and Hastings JW. Bacterial bioluminescence: its control and ecological significance. Microbiol Rev 1979; 43: 496-518.
50. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF and Thery C. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 2010; 12: 19-30; sup pp 11-13.
51. Tolmachova T, Anders R, Stinchcombe J, Bossi G, Griffiths GM, Huxley C and Seabra MC. A general role for Rab27a in secretory cells. Mol Biol Cell 2004; 15: 332-344.
52. Spiegelberg HL and Fishkin BG. Human myeloma IgA half-molecules. J Clin Invest 1976; 58: 1259-1265.
53. Wang Q, Ni Q, Wang X, Zhu H, Wang Z and Huang J. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival. Med Oncol 2015; 32: 372.
54. Raimondo S, Saieva L, Corrado C, Fontana S, Flugy A, Rizzo A, De Leo G and Alessandro R. Chronic myeloid leukemia-derived exosomes promote tumor growth through an autocrine mechanism. Cell Commun Signal 2015; 13: 8.